Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection

June 28, 2022 updated by: Yuan-Yi Chia, Kaohsiung Veterans General Hospital.

Restrictive Versus Liberal Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection: a Prospective Randomised Trial of Perioperative Quality of Care

Studies have demonstrated that the rate of change in stroke volume variation (SVV) can be used to determine the volume of body fluids during major abdominal surgery. Anaesthesiologists can use SVV as a guide for the appropriate administration of intraoperative fluids to improve postoperative prognoses. Liver surgery is a major abdominal operation, and the amount of blood lost is typically higher than that during other general abdominal surgeries. Blood loss is positively correlated with the intraoperative fluid infusion volume, and greater blood loss is associated with more postoperative complications. Additionally, comorbid liver disease or cirrhosis can increase the complexity of liver tumour resection, causing difficulty in assessing intravascular volume and determining the appropriate intraoperative infusion volume.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaohsiung, Taiwan, 81362
        • Kaohsiung Veterans General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • We initially selected 118 patients who required hepatectomy.
  • The physiological status of the patients was assessed in terms of American Society of Anesthesiologists scores I-III

Exclusion Criteria:

  • Extreme body mass index (BMI)
  • Age under 20 or over 75 years
  • Emergency surgery
  • Preexisting cardiac, hepatic, renal, or coagulation disorder; hyperthyroidism; and sinus arrhythmia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: the low-SVV group
the value of stroke volume variation will be less than or equal to 10 this group
fluid will be guided by value of stroke volume variation
Active Comparator: the high-SVV group
the value of stroke volume variation will be higher than 10 this group
fluid will be guided by value of stroke volume variation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postoperative complications in the two groups.
Time Frame: From day 1 to day 30 after surgery.
calculate the incidence of postoperative complication within 30 days
From day 1 to day 30 after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The differences of perioperative ALT
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative eGFR
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative creatinine
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative T.bil
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative Hb
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative arterial lactate
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The differences of perioperative albumin
Time Frame: Examination report on the 1st postoperative day.
Calculate the difference of the perioperative physiological variables
Examination report on the 1st postoperative day.
The pain scale
Time Frame: up to three days postoperatively
Assessment of postoperative pain scale
up to three days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuan-Yi Chia, Director, Kaohsiung Veterans General Hospital.
  • Study Director: Kai-Wei Hsieh, physician, Kaohsiung Veterans General Hospital.
  • Study Chair: We-Yu Chen, physician, Kaohsiung Veterans General Hospital.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

April 29, 2022

First Submitted That Met QC Criteria

April 29, 2022

First Posted (Actual)

May 4, 2022

Study Record Updates

Last Update Posted (Actual)

July 1, 2022

Last Update Submitted That Met QC Criteria

June 28, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe